^
    3years
    LEAC-102 for Advanced Colorectal Cancer (clinicaltrials.gov)
    P1/2, N=30, Not yet recruiting, Taiwan Leader Biotech Corp. | Trial completion date: Feb 2022 --> Feb 2024 | Trial primary completion date: Feb 2022 --> Feb 2024
    Clinical • Trial completion date • Trial primary completion date • Combination therapy
    |
    CRP (C-reactive protein)
    |
    Avastin (bevacizumab) • Erbitux (cetuximab) • 5-fluorouracil • leucovorin calcium • LEAC-102